Bull case
XYL would need investors to value it at roughly 33x earnings — about 11x more generous than today's 21x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where XYL stock could go
XYL would need investors to value it at roughly 33x earnings — about 11x more generous than today's 21x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 30x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 9x multiple contraction could push XYL down roughly 42% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Xylem is a global water technology company that designs, manufactures, and services engineered products and solutions for water and wastewater applications. It generates revenue through three main segments: Water Infrastructure (~45% of sales), Applied Water (~35%), and Measurement & Control Solutions (~20%), selling pumps, treatment equipment, smart meters, and related services. The company's competitive advantage lies in its comprehensive portfolio of trusted brands—Flygt, Godwin, Goulds, and others—and deep technical expertise across the entire water cycle, creating high switching costs for utilities and industrial customers.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.26/$1.15 | +9.6% | $2.3B/$2.2B | +4.2% |
| Q4 2025 | $1.37/$1.23 | +11.4% | $2.3B/$2.2B | +2.0% |
| Q1 2026 | $1.42/$1.41 | +0.7% | $2.4B/$2.4B | +1.1% |
| Q2 2026 | $1.12/$1.09 | +2.8% | $2.1B/$2.1B | +0.7% |
XYL beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $115 — implies -0.0% from today's price.
| Metric | XYL | S&P 500 | Industrials | 5Y Avg XYL |
|---|---|---|---|---|
| Forward PE | 21.4x | 19.1x+12% | 20.8x | — |
| Trailing PE | 30.3x | 25.2x+20% | 25.9x+17% | 43.0x-30% |
| PEG Ratio | 1.32x | 1.75x-24% | 1.59x-17% | — |
| EV/EBITDA | 15.9x | 15.3x | 13.9x+15% | 22.7x-30% |
| Price/FCF | 31.0x | 21.3x+45% | 20.6x+50% | 45.6x-32% |
| Price/Sales | 3.1x | 3.1x | 1.6x+96% | 3.6x-14% |
| Dividend Yield | 1.35% | 1.88% | 1.24% | 1.13% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolXYL generates $966M in free cash flow at a 10.6% margin — returns 1.4% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~0.5 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 11, 2026
Xylem’s shares may be trading at a premium relative to peers, leaving little margin for error if earnings or revenue miss expectations. A shortfall could trigger a sharp price correction, impacting shareholder returns.
The company’s current ratio of 1.63 indicates that current assets barely cover short‑term liabilities, limiting financial flexibility. Tight liquidity could constrain working capital and ability to fund operations during downturns.
Evoqua and the planned Idrica acquisition carry integration challenges that could delay synergy realization. Failure to integrate effectively could erode projected revenue and margin gains.
Delays in government water infrastructure funding or the timing of large smart‑metering contracts can postpone revenue recognition. Such timing uncertainties may compress quarterly earnings.
Competitors may undercut Xylem’s higher‑margin business, eroding market share and pressuring margins. Price wars could reduce profitability over the long term.
The 80/20 profitability focus may slow short‑term revenue growth, creating a window for competitors to capture market share. Investors may see a temporary dip in top‑line growth.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 11, 2026
Xylem has posted year‑over‑year revenue growth and a solid net profit margin of 10.6%. The company reported record quarterly EBITDA margins and earnings per share, with expectations for continued earnings growth.
The acquisition of Evoqua is expected to significantly enhance Xylem's growth profile and operational performance, boosting margins. The company is also planning a majority stake in Idrica and has accelerated synergy targets related to the Evoqua integration.
In February 2026, Xylem approved a new share repurchase program authorizing up to $1.5 billion of its own stock. The program complements an 8% dividend increase, underscoring the company's commitment to returning capital to shareholders.
Xylem Vue digital revenue is targeting over 30% growth, contributing to recurring higher‑margin revenue. Integration benefits and digital expansion justify a premium valuation.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
XYL XYL Xylem Inc. | $28.2B | 21.4x | +6.5% | 10.7% | Hold | +27.8% |
PNR PNR Pentair plc | $12.9B | 14.9x | +2.4% | 16.0% | Hold | +42.0% |
FEL FELE Franklin Electric Co., Inc. | $4.5B | 22.0x | +5.0% | 6.9% | Hold | -1.0% |
GFF GFF Griffon Corporation | $4.3B | 17.7x | -5.2% | 1.8% | Buy | +20.4% |
DHR DHR Danaher Corporation | $123.8B | 20.7x | +1.8% | 14.9% | Buy | +41.2% |
ITT ITT ITT Inc. | $19.4B | 28.3x | +14.2% | 10.8% | Buy | +6.0% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
XYL returns 1.4% total yield, led by a 1.35% dividend, raised 15 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.43 | — | — | — |
| 2025 | $1.60 | +11.1% | 0.0% | 1.2% |
| 2024 | $1.44 | +9.1% | 0.1% | 1.3% |
| 2023 | $1.32 | +10.0% | 0.1% | 1.3% |
| 2022 | $1.20 | +7.1% | 0.3% | 1.3% |
Common questions answered from live analyst data and company financials.
Xylem Inc. (XYL) is rated Hold by Wall Street analysts as of 2026. Of 40 analysts covering the stock, 18 rate it Buy or Strong Buy, 21 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $152, implying +27.8% from the current price of $119. The bear case scenario is $69 and the bull case is $181.
The Wall Street consensus price target for XYL is $152 based on 40 analyst estimates. The high-end target is $161 (+35.8% from today), and the low-end target is $133 (+12.2%). The base case model target is $166.
XYL trades at 21.4x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals fairly valued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for XYL in 2026 are: (1) Valuation Premium Risk — Xylem’s shares may be trading at a premium relative to peers, leaving little margin for error if earnings or revenue miss expectations. (2) Liquidity Constraint — The company’s current ratio of 1. (3) Acquisition Integration Risk — Evoqua and the planned Idrica acquisition carry integration challenges that could delay synergy realization. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates XYL will report consensus revenue of $9.7B (+6.5% year-over-year) and EPS of $5.02 (+25.7% year-over-year) for the upcoming fiscal year. The following year, analysts project $10.6B in revenue.
A confirmed upcoming earnings date for XYL is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
Xylem Inc. (XYL) generated $966M in free cash flow over the trailing twelve months — a free cash flow margin of 10.6%. XYL returns capital to shareholders through dividends (1.4% yield) and share repurchases ($15M TTM).